You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Primary CNS lymphomas (PCNSL) are increasing in incidence. Current treatments offer a median survival of 17-44 months, similar to glioblastoma.
Area of Science:
Background:
Discussion:
Key Insights:
Outlook: